Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of HSK21542 injection for postoperative analgesia after orthopedic surgery
CTR20221996Phase 2Active
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Sep 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of hsk21542 in postoperative pain, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Sep 2022; status: active.
02
Drugs
hsk21542
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20221996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221996.